Gene Therapy for Cardiovascular DiseasesYLÄ-HERTTUALA, S.Annals of medicine (Helsinki). 1996, Vol 28, Num 2, pp 89-93, issn 0785-3890Article

Artifact occurring during combined in situ hybridization and immunocytochemistry analysis because of positive chemographyHÄKKINEN, T; YLÄ-HERTTUALA, S.BioTechniques. 1998, Vol 24, Num 5, pp 730-732, issn 0736-6205, 2 p.Article

Effect of post-mortem time on the biochemical composition of coronary arteriesYLA-HERTTUALA, S; NIKKARI, T.Atherosclerosis. 1985, Vol 56, Num 1, pp 1-10, issn 0021-9150Article

METABOLISM OF GLYCOS AMINOGLYCANS AND LIPIDS IN SMOOTH MUSCLE CELLS FROM ATHEROSCLEROTIC RABBIT AORTAS IN CULTUREPIETILA K; YLA HERTTUALA S; JAAKKOLA O et al.1980; ATHEROSCLEROSIS; ISSN 0021-9150; NLD; DA. 1980; VOL. 37; NO 3; PP. 449-456; BIBL. 20 REF.Article

Gene therapy of atherosclerosisVÄHÄKANSAS, E; YLÄ-HERTTUALA, S.Handbook of experimental pharmacology. 2005, Vol 170, pp 785-807, issn 0171-2004, 23 p.Article

Post-intervention vessel remodelingRUTANEN, J; PUHAKKA, H; YLÄ-HERTTUALA, S et al.Gene therapy (Basingstoke). 2002, Vol 9, Num 22, pp 1487-1491, issn 0969-7128, 5 p.Article

Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinicRISSANEN, T. T; VAJANTO, I; YLÄ-HERTTUALA, S et al.European journal of clinical investigation. 2001, Vol 31, Num 8, pp 651-666, issn 0014-2972Article

Retrovirus-mediated, stable scavenger-receptor gene transfer leads to functional endocytotic receptor expression, foam cell formation, and increased susceptibility to apoptosis in rabbit aortic smooth muscle cellsLEHTOLAINEN, P; TAKEYA, M; YLÄ-HERTTUALA, S et al.Arteriosclerosis, thrombosis, and vascular biology. 2000, Vol 20, Num 1, pp 52-60, issn 1079-5642Article

Progress and prospects: hurdles to cardiovascular gene therapy clinical trialsHEDMAN, M; HARTIKAINEN, J; YLÄ-HERTTUALA, S et al.Gene therapy (Basingstoke). 2011, Vol 18, Num 8, pp 743-749, issn 0969-7128, 7 p.Article

Cardiovascular gene therapyYLÄ-HERTTUALA, S; MARTIN, J. F.Lancet (British edition). 2000, Vol 355, Num 9199, pp 213-222, issn 0140-6736Article

Expression of inducible nitric oxide synthase in macrophages and smooth muscle cells in various types of human atherosclerotic lesionsLUOMA, J. S; YLÄ-HERTTUALA, S.Virchows Archiv. 1999, Vol 434, Num 6, pp 561-568, issn 0945-6317Article

Angiogenic gene therapy, a novel treatment paradigm for coronary artery diseaseYLÄ-HERTTUALA, S; DZAU, V. J.European heart journal supplements. 2004, Vol 6, Num E, issn 1520-765X, 37 p.Conference Proceedings

A PCR artifact under low-stringency conditions due to amplification by only one primerHILTUNEN, T; RAJA-HONKALA, M; NIKKARI, T et al.BioTechniques. 1994, Vol 17, Num 2, pp 240-242, issn 0736-6205, 2 p.Article

VEGF-A,VEGF-D and VEGF-D^ΔNΔC induced intimal hyperplasia in carotid arteriesBHARDWAJ, S; ROY, H; HEIKURA, T et al.European journal of clinical investigation. 2005, Vol 35, Num 11, pp 669-676, issn 0014-2972, 8 p.Article

Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbitsYLITALO, R; OKSALA, O; YLÄ-HERTTUALA, S et al.The Journal of laboratory and clinical medicine. 1994, Vol 123, Num 5, pp 769-776, issn 0022-2143Article

Severe hyperlipoproteinemia in congenital nephrotic syndrome of the Finnish type : effect of dialysis and kidney transplantationSALO, M. K; JAAKKOLA, O; SOLAKIVI, T et al.Acta paediatrica (Oslo). 1993, Vol 82, Num 9, pp 768-772, issn 0803-5253Article

Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesionsHILTUNEN, T; LUOMA, J; NIKKARI, T et al.Circulation (New York, N.Y.). 1995, Vol 92, Num 11, pp 3297-3303, issn 0009-7322Article

Down's syndrome and atherosclerosisYLA-HERTTUALA, S; LUOMA, J; NIKKARI, T et al.Atherosclerosis. 1989, Vol 76, Num 2-3, pp 269-272, issn 0021-9150Article

Macrophage foam cells from human aortic fatty streaks take up β-VLDL and acetylated LDL in primary cultureJAAKKOLA, O; YLA-HERTTUALA, S; SARKIOJA, T et al.Atherosclerosis. 1989, Vol 79, Num 2-3, pp 173-182, issn 0021-9150Article

Receptor-mediated binding and degradation of subfractions of human plasma low-density lipoprotein by cultured fibroblastsJAAKKOLA, O; SOLAKIVI, T; YLA-HERTTUALA, S et al.Biochimica et biophysica acta. 1989, Vol 1005, Num 2, pp 118-122, issn 0006-3002Article

Insights into the molecular pathogenesis of atherosclerosis and therapeutic strategies using gene transferHILTUNEN, M. O; TURUNEN, M. P; LAITINEN, M et al.Vascular medicine (London). 2000, Vol 5, Num 1, pp 41-48, issn 1358-863XArticle

Characterization of atherosclerotic lesions in apo E3-leiden transgenic miceLEPPÄNEN, P; LUOMA, J. S; HOFKER, M. H et al.Atherosclerosis. 1998, Vol 136, Num 1, pp 147-152, issn 0021-9150Article

Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions : Marked induction of scavenger receptor and VLDL receptor expression during lesion developmentHILTUNEN, T. P; LUOMA, J. S; NIKKARI, T et al.Circulation (New York, N.Y.). 1998, Vol 97, Num 11, pp 1079-1086, issn 0009-7322Article

10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limbMUONA, K; MÄKINEN, K; HEDMAN, M et al.Gene therapy (Basingstoke). 2012, Vol 19, Num 4, pp 392-395, issn 0969-7128, 4 p.Article

Antegrade flow and peripheral resistance determine the level of endogenous arteriogenesis in patients with superficial femoral artery occlusionVAJANTO, I; KORPISALO, P; KARJALAINEN, J et al.European journal of clinical investigation. 2009, Vol 39, Num 12, pp 1048-1054, issn 0014-2972, 7 p.Article